Influenza A virus DNA vaccine H5N1 (Vical)

N/A

Report date: 2024/05/17 20:00:39

Base Information

Drug NameInfluenza A virus DNA vaccine H5N1 (Vical)
Drug Alias NameVCL-IPT1Vaxfectin-formulated plasmid DNA vaccine H5N1 - VicalVCL-IPM1Pandemic influenza plasmid DNA vaccine H5N1 - VicalInfluenza A (H5N1) DNA vaccine - Vical +[6] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVical Incorporated
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A